SJUTS DUSTIN S (Chief Commercial Officer) sold 5.2% of their position (9.21K shares) of REVANCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $46.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2024ACC: 0001479290-24-000068
Officer· Chief Commercial Officer
Since Dec 2019
-12.18K
Net shares
Net seller
$62.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
12.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.97K
Price / share
$5.30
Trade value
$15.74K
% of position
1.7%
3/15/2024
179.73K→176.76K
Common Stock
Direct
Shares
−9.21K
Price / share
$5.04
Trade value
$46.45K
% of position
5.2%
3/18/2024
176.76K→167.55K
Total
Net shares
−12.18K
Net value
-$62.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2024 | F · Tax Withholding | −2.97K | $5.30 | $15.74K | 1.7% | 179.73K | 176.76K |
| Common Stock Direct | 3/18/2024 | S · Sale | −9.21K | $5.04 | $46.45K | 5.2% | 176.76K | 167.55K |
| Total | −12.18K | -$62.19K | ||||||
Derivative Transactions0
No derivative transactions reported